Bluepharma, a Portuguese pharmaceutical company, has just opened a state-of-the-art industrial unit specialised in the production of oral solid high potent drugs, namely in the oncology area. The [...]

US Biopharmaceutical company Amgen is to invest €100 million in a hub in Portugal that will eventually create 300 new job posts. The Amgen Capability Center Portugal (ACCP) has already hired 170 [...]

Delegates that took part at Portugal’s Pharmaceutical Industry Forum agreed that there are opportunities for Europe’s reindustrialisation and in the reconfiguration of supply chains. However, the [...]

The Portuguese pharmaceutical company Bluepharma is to invest €150 million to 2030 in the creation of a pharma technology hub in the country’s university city of Coimbra. The hub will also [...]

The Portuguese pharmaceutical company Hovione is to invest €150 million in expanding its factories. Around €75 million will be invested in Portugal while the rest will be spent in the US and [...]

Bial to sell Parkinson drug in Europe The Portuguese pharmaceutical company Bial has reached an agreement with the US company Sunovion to sell a drug which treats Parkinson in Europe. Under the [...]